Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Naloxone for Preventing Morbidity and Mortality in Newborn Infants of Greater Than 34 Weeks' Gestation With Suspected Perinatal Asphyxia." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432446/all/images/closex.png. Accessed 28 April 2024.
Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432446/all/images/closex.png. Accessed April 28, 2024.
Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432446/all/images/closex.png
Naloxone for Preventing Morbidity and Mortality in Newborn Infants of Greater Than 34 Weeks' Gestation With Suspected Perinatal Asphyxia [Internet]. In: Cochrane Abstracts. [cited 2024 April 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432446/all/images/closex.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia
ID - 432446
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432446/all/images/closex.png
DB - Evidence Central
DP - Unbound Medicine
ER -